Tag: Pharma
Biophytis and Innovation Solutions Pharma sign a partnership to accelerate market access for Sarconeos (BIO101) in Brazil – 10/30/2023 at 06:00
Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis”), a clinical-stage biotechnology company specializing in the development of treatments that aim to slow down the degenerative processes linked to…
TME PHARMA PUBLISHES ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2023 AND PROVIDES AN UPDATE ON ITS ACTIVITY – 10/27/2023 at 6:00 p.m.
• Survival data from the phase 1/2 NOX-A12 GLORIA trial in brain cancer continues to improve and has already exceeded that of all competing treatments. • 67% overall survival at…
MEDESIS PHARMA: ACTIVITIES & RESULTS OF THE 1ST HALF 2023 – 10/27/2023 at 6:00 p.m.
Montpellier, October 27, 2023 at 6:00 p.m. – MEDESIS PHARMA, a pharmaceutical biotechnology company developing drug candidates based on its proprietary technology for administering active ingredients in nano micelles orally,…
Medesis Pharma seeking new financing – 10/27/2023 at 6:15 p.m.
(AOF) – Medesis Pharma announces that its cash flow as of June 30, 2023 amounts to 139,000 euros, which gives it visibility “until the end of November 2023”. The biotech…
TME Pharma: 3 million euros in cash as of June 30, visibility until February 2024 – 10/27/2023 at 6:17 p.m.
(AOF) – “Given cash and cash equivalents of 3 million euros as of June 30, 2023”, TME Pharma “has financial visibility until February 2024”. This is what the biotech specialist…
Medesis Pharma seeking new financing
(AOF) – Medesis Pharma announces that its cash flow as of June 30, 2023 amounts to 139,000 euros, which gives it visibility “until the end of November 2023”. The biotech…
TME Pharma: 3 million euros in cash as of June 30, visibility until February 2024
(AOF) – “Given cash and cash equivalents of 3 million euros as of June 30, 2023”, TME Pharma “has financial visibility until February 2024”. This is what the biotech specialist…
Mithra will receive a milestone payment of 2.5 million euros from Fuji Pharma under the license agreement for ESTELLE® – 10/23/2023 at 07:30
Mithra will receive a milestone payment of 2.5 million euros from Fuji Pharma under the license agreement for ESTELLE®• This payment will follow the submission of an application for marketing…
TME Pharma: new data in brain cancer – 10/20/2023 at 11:45
(CercleFinance.com) – TME Pharma reported new positive data on Friday in aggressive brain cancer in adults, which allowed its stock to rebound on Friday on the Paris Stock Exchange. The…
TME PHARMA ANNOUNCES THE END OF THE SIX-MONTH LOCK-UP PERIOD OF SHARES AND CONVERTIBLE BONDS FOLLOWING THE APRIL 2023 FINANCIAL TRANSACTION – 10/17/2023 at 7:00 p.m.
Berlin, Germany, October 17, 2023, 7:00 p.m. CEST – TME Pharma NV (Euronext Growth Paris: ALTME), a biotechnology company specializing in the development of novel therapies for the treatment of…
Innate Pharma on the rise: several presentations planned at the Esmo congress – 10/16/2023 at 09:48
(AOF) – Innate Pharma (+3% to 2.23 euros) posts one of the strongest increases in the SRD market after the announcement that several abstracts are selected for the European Society…
ABIONYX Pharma selected as Late-Breaking Clinical Results Poster Presentation during “Kidney Week” of the 2023 Annual Meeting of the American Society of Nephrology (ASN) for clinical data from the RACERS phase 2 study in sepsis – 16/10/2023 at 07:00
• The “Late-Breaking Clinical Results” session will present a world premiere of clinical data from the RACERS study in sepsis having achieved the primary and secondary objective of the study…